Filing Flows › Comparisons › PTN vs BIOA
Palatin Technologies vs BioAge Labs: PTN and BIOA compared
Palatin Technologies is the larger company: $301K of revenue in its latest quarter (Q4 FY26) against $298K for BioAge Labs (Q3 2026).
Where the money goes: PTN and BIOA
Palatin Technologies (PTN) · Q4 FY26
Palatin Technologies, Q4 FY26: revenue $301K, net loss $4.4M, operating cash flow −$2.7M. The chart follows the revenue to costs, profit and cash.
BioAge Labs (BIOA) · Q3 2026
BioAge Labs, Q3 2026: revenue $298K (-86% year over year), net loss $33.5M, operating cash flow −$31.0M. The chart follows the revenue to costs, profit and cash.
| Palatin Technologies (PTN) | BioAge Labs (BIOA) | |
|---|---|---|
| Latest quarter | Q4 FY26 | Q3 2026 |
| Revenue | $301K | $298K |
| Revenue growth, Y/Y | — | -86% |
| Operating margin | n/m | n/m |
| Net earnings | −$4.4M | −$33.5M |
| Operating cash flow | −$2.7M | −$31.0M |
Questions
Which is bigger, Palatin Technologies or BioAge Labs?
Palatin Technologies is the larger company: $301K of revenue in its latest quarter (Q4 FY26) against $298K for BioAge Labs (Q3 2026).
More: Palatin Technologies earnings · how Palatin Technologies makes money · BioAge Labs earnings · how BioAge Labs makes money
From the companies' latest 10-Q, 10-K or earnings release (10-K filed Sep 28, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.